Bio­haven aims to raise $250M; Ac­tivist in­vestor's stake in Gala­pa­gos ex­ceeds 10%

Plus, news about IN8bio, Sanofi, Vi­core Phar­ma, Carther­ics, Zephyrm Bio­science, Tharim­mune and In­tract Phar­ma:

Bio­haven’s $250M of­fer­ing: The move comes af­ter Bio­haven an­nounced Mon­day that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER